Levi Strauss shares surge 31 percent in stock market return
March 21, 2019Ethiopia says U.S., EU, French teams helping analyze crash black boxes
March 21, 2019Biogen scraps Alzheimer drug trials, wiping $17 billion off its market value
at
Reuters – Biogen and partner Eisai Co Ltd are ending two late-stage trials for the experimental Alzheimer’s drug aducanumab, in a setback to efforts to find treatments for the disease and for Biogen’s stock, which lost more than $17 billion of its value on Thursday.
Powered by WPeMatico
